Table 3.
HC | PD-noCI | PD-MCI | PDD | DLB | |
---|---|---|---|---|---|
n | 9 | 8 | 9 | 15 | 6 |
Occipital | 0.14 (0.08) | 0.10 (0.09) | 0.14 (0.19) | 0.08 (0.09) | 0.08 (0.06) |
Prefrontal* | 0.08 (0.18) | 0.05 (0.18) | 0.05 (0.24) | 0.11 (0.27) | 0.18 (0.32) |
Gyrus Rectus* | 0.00 (0.10) | 0.00 (0.11) | 0.00 (0.20) | 0.08 (0.25) | 0.16 (0.27) |
Temporal* | 0.08 (0.11) | 0.03 (0.12) | 0.05 (0.18) | 0.10 (0.19) | 0.17 (0.21) |
Precuneus* | 0.15 (0.13) | 0.09 (0.17) | 0.22 (0.25) | 0.17 (0.28) | 0.21 (0.28) |
Caudate | −0.08 (0.11) | −0.05 (0.19) | −0.08 (0.13) | −0.00 (0.18) | 0.02 (0.22) |
MCBP | 0.08 (0.13) | 0.04 (0.14) | 0.08 (0.21) | 0.11 (0.24) | 0.18 (0.26) |
Binding potentials are shown as mean (SD). Cortical regions included in MCBP calculation are indicated with an asterisk (*).
PIB = Pittsburgh Compound B; MCBP = mean cortical binding potential; HC = healthy control; PD-noCI = Parkinson disease without cognitive impairment; PD-MCI = Parkinson disease with mild cognitive impairment; PDD = Parkinson disease with dementia; DLB = Dementia with Lewy bodies.